Bluebird Bio Receives FDA Breakthrough Therapy Designation For Lentiglobin Drug Therapy By: TalkMarkets February 02, 2015 at 19:07 PM EST Despite the designation, shares remained flat. Read More >> Related Stocks: Bluebird Bio